Dyadic International: Funding, Investors & Team (Sep 2026)
Dyadic International, Inc. is a global biotechnology company based in Jupiter, Florida, with a research facility in the Netherlands. Using its unique technologies, Dyadic conducts research and development in order to discover, develop, manufacture, and sell enzymes and other proteins for various industries. The company's integrated technology platform, based on its patented C1 fungus, allows for the cost-effective production of enzymes and proteins for different market uses. Dyadic also explores partnerships and licensing opportunities to share the benefits of its technologies with others, enabling the production and utilization of the enzymes they help create.
Dyadic International has raised $6.0M across 1 funding round on record, the most recent an undisclosed round of $6.0M announced in Mar 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dyadic International Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Dyadic International Funding Rounds
Dyadic International Founders and Leadership Team
No contact details are on record for this team yet.
Dyadic International Funding Compared to Other Biotechnology Startups
Dyadic International's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dyadic International in Biotechnology and Jupiter
Companies Similar to Dyadic International
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Dyadic International Funding FAQs
What does Dyadic International do?
Dyadic International, Inc. is a global biotechnology company based in Jupiter, Florida, with a research facility in the Netherlands. Using its unique technologies, Dyadic conducts research and development in order to discover, develop, manufacture, and sell enzymes and other proteins for various industries. The company's integrated technology platform, based on its patented C1 fungus, allows for the cost-effective production of enzymes and proteins for different market uses. Dyadic also explores partnerships and licensing opportunities to share the benefits of its technologies with others, enabling the production and utilization of the enzymes they help create.
How much funding has Dyadic International raised?
Dyadic International has raised $6.0M across 1 round on record. The most recent is an undisclosed round of $6.0M announced in Mar 2024.
When did Dyadic International last raise funding?
Dyadic International's most recent funding round on record is an undisclosed round of $6.0M, announced in Mar 2024.
Who founded Dyadic International?
FundedIQ lists Mark A Emalfarb (Founder) at Dyadic International.
Where is Dyadic International headquartered?
Dyadic International is based in Jupiter, Florida, United States.
How many employees does Dyadic International have?
Dyadic International is in the 51-100 employee band.
How does Dyadic International's funding compare to other Biotechnology startups?
Dyadic International's latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Dyadic International Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dyadic International is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.